AstraZeneca (AZN) volatility elevated into shares selling off on failed drug trial
Tweet
Share
E-mail
Get Alerts AZN Hot Sheet
Join SI Premium – FREE
AstraZeneca (NYSE: AZN) July call option implied volatility is at 100, August is at 53; compared to its 52-week range of 20 to 57 into a failed drug trial.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sixth Street renews bid for Brighthouse Financial amid rival deal delays
- Capri Holdings Limited (CPRI) 15K contracts of October 15 calls trade, share price up 6.9%
- Energy Select Sector SPDR ETF (XLE) call put ratio 1 call to 1 put amid energy price movement
Create E-mail Alert Related Categories
Options, Trader TalkRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
